Letter to the editor: Comments on 'A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation'.

Eur J Cancer

Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address:

Published: October 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.07.014DOI Listing

Publication Analysis

Top Keywords

letter editor
4
editor comments
4
comments six-weekly
4
six-weekly dosing
4
dosing schedule
4
schedule pembrolizumab
4
pembrolizumab patients
4
patients cancer
4
cancer based
4
based evaluation
4

Similar Publications

This Letter to the Editor responds to the recent publication by Patel et al. (J Robot Surg. Jul 11;19(1):370, 2025), which outlines a framework and recommendations for telesurgery.

View Article and Find Full Text PDF